ELTX
Elicio Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$12.20
+1.30 ▲ +11.93%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$12.20
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -2.56 | Insider Own | 34.87% | Shs Outstand | 0.02B | Perf Week | 4.9% |
| Market Cap | 0.22B | Forward P/E | - | EPS next Y | 6.35% | Insider Trans | - | Shs Float | 0.01B | Perf Month | 45.24% |
| Enterprise Value | 0.22B | PEG | - | EPS next Q | -0.42 | Inst Own | 12.05% | Short Float | 11.43% | Perf Quarter | 51.55% |
| Income | -0.04B | P/S | - | EPS this Y | 42.05% | Inst Trans | 3.37% | Short Ratio | 10.08 | Perf Half Y | 5.35% |
| Sales | 0.00B | P/B | 132.74 | EPS next 5Y | 17.48% | ROA | -146.45% | Short Interest | 1.30M | Perf YTD | 53.27% |
| Book/sh | 0.09 | P/C | 12.09 | EPS past 3/5Y | 85.75% 37.53% | ROE | -60013.19% | 52W High | -18.29% ($14.93) | Perf Year | 54.43% |
| Cash/sh | 1.01 | P/FCF | - | Sales past 3/5Y | - | ROIC | -261.42% | 52W Low | 165.22% ($4.60) | Perf 3Y | 121.82% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 42.43% | Gross Margin | - | Volatility(W/M) | 13.71% 10.94% | Perf 5Y | -94.03% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.18 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.38 | EPS Q/Q | 65.85% | Profit Margin | - | RSI (14) | 59.05 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.38 | Sales Q/Q | - | SMA20 | 10.93% ($11) | Beta | 1.1 | Target Price | $17.33 |
| Payout | - | Debt/Eq | 8.85 | Earnings | 3000000 | SMA50 | 31.57% ($9.27) | Rel Volume | 1.27 | Prev Close | $10.9 |
| Employees | 33 | LT Debt/Eq | 8.23 | EPS/Sales Surpr. | -1.12% - | SMA200 | 30.86% ($9.32) | Avg Volume(3M) | 0.13M | Price | $12.2 |
| IPO | 2021/2/5 | Option/Short | Yes/Yes | Trades | 1837 | Volume | 163,806 | Change | 11.93% |
뉴스 로딩 중...